Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 9613

1.

TMD and chronic pain: A current view.

Furquim BD, Flamengui LM, Conti PC.

Dental Press J Orthod. 2015 Jan-Feb;20(1):127-133.

PMID:
25741834
[PubMed - as supplied by publisher]
2.

Treatment of irritable bowel syndrome in China: A review.

Li CY, Li SC.

World J Gastroenterol. 2015 Feb 28;21(8):2315-2322. Review.

PMID:
25741137
[PubMed - as supplied by publisher]
Free Article
3.

Acacia ferruginea inhibits inflammation by regulating inflammatory iNOS and COX-2.

Sakthivel KM, Guruvayoorappan C.

J Immunotoxicol. 2015 Mar 4:1-9. [Epub ahead of print]

PMID:
25738525
[PubMed - as supplied by publisher]
4.

Motility disorders, functional gastrointestinal disorders, inflammatory bowel disease and cardiac rhythm disturbances - is there a link? Review of literature.

Żorniak M, Walug M, Hartle M.

Curr Drug Targets. 2015 Mar 3. [Epub ahead of print]

PMID:
25738294
[PubMed - as supplied by publisher]
5.

Diagnosis and management of irritable bowel syndrome in adults in primary care: summary of NICE guidance.

[No authors listed]

BMJ. 2015 Mar 3;350:h1216. doi: 10.1136/bmj.h1216. No abstract available.

PMID:
25736443
[PubMed - in process]
6.

Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study.

Koloski NA, Jones M, Young M, Talley NJ.

Aliment Pharmacol Ther. 2015 Mar 4. doi: 10.1111/apt.13149. [Epub ahead of print]

PMID:
25736433
[PubMed - as supplied by publisher]
7.

Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients.

Miller V, Carruthers HR, Morris J, Hasan SS, Archbold S, Whorwell PJ.

Aliment Pharmacol Ther. 2015 Mar 4. doi: 10.1111/apt.13145. [Epub ahead of print]

PMID:
25736234
[PubMed - as supplied by publisher]
8.

Disease-Related Differences in Resting State Networks: A Comparison between Localized Provoked Vulvodynia, Irritable Bowel Syndrome, and Healthy Control Subjects.

Gupta A, Rapkin AJ, Gill Z, Kilpatrick L, Fling C, Stains J, Masghati S, Tillisch K, Mayer EA, Labus JS.

Pain. 2015 Feb 12. [Epub ahead of print]

PMID:
25735001
[PubMed - as supplied by publisher]
9.

JAMA patient page. Irritable bowel syndrome.

Chey WD, Eswaran S, Kurlander J.

JAMA. 2015 Mar 3;313(9):982. doi: 10.1001/jama.2015.0958. No abstract available.

PMID:
25734751
[PubMed - in process]
10.

Irritable bowel syndrome: a clinical review.

Chey WD, Kurlander J, Eswaran S.

JAMA. 2015 Mar 3;313(9):949-58. doi: 10.1001/jama.2015.0954.

PMID:
25734736
[PubMed - in process]
11.

IBS-like symptoms in patients with ulcerative colitis.

Gracie DJ, Ford AC.

Clin Exp Gastroenterol. 2015 Feb 19;8:101-9. doi: 10.2147/CEG.S58153. eCollection 2015. Review.

PMID:
25733921
[PubMed]
Free PMC Article
12.

A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin, and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS.

Menees SB, Powell C, Kurlander J, Goel A, Chey WD.

Am J Gastroenterol. 2015 Mar 3. doi: 10.1038/ajg.2015.6. [Epub ahead of print]

PMID:
25732419
[PubMed - as supplied by publisher]
13.

Emerging drug for diarrhea predominant irritable bowel syndrome.

Deiana S, Gabbani T, Bagnoli S, Annese V.

Expert Opin Emerg Drugs. 2015 Mar 3:1-15. [Epub ahead of print]

PMID:
25732091
[PubMed - as supplied by publisher]
14.

Irritable Bowel Syndrome: Modern Concepts and Management Options.

Sayuk GS, Gyawali CP.

Am J Med. 2015 Feb 27. pii: S0002-9343(15)00168-0. doi: 10.1016/j.amjmed.2015.01.036. [Epub ahead of print] Review.

PMID:
25731138
[PubMed - as supplied by publisher]
15.

Lubiprostone in constipation: clinical evidence and place in therapy.

Wilson N, Schey R.

Ther Adv Chronic Dis. 2015 Mar;6(2):40-50. doi: 10.1177/2040622314567678. Review.

PMID:
25729555
[PubMed]
Free PMC Article
16.

Functional gastrointestinal disorders in 35 447 adults and their association with body mass index.

Le Pluart D, Sabaté JM, Bouchoucha M, Hercberg S, Benamouzig R, Julia C.

Aliment Pharmacol Ther. 2015 Mar 1. doi: 10.1111/apt.13143. [Epub ahead of print]

PMID:
25728697
[PubMed - as supplied by publisher]
17.

Quality of life in patients with different constipation subtypes based on the Rome III criteria.

Ruiz-López MC, Coss-Adame E.

Rev Gastroenterol Mex. 2015 Feb 25. pii: S0375-0906(15)00008-7. doi: 10.1016/j.rgmx.2015.01.003. [Epub ahead of print] English, Spanish.

PMID:
25726441
[PubMed - as supplied by publisher]
Free Article
18.

Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients.

Hall KT, Tolkin BR, Chinn GM, Kirsch I, Kelley JM, Lembo AJ, Kaptchuk TJ, Kokkotou E, Davis RB, Conboy LA.

Brain Behav. 2015 Jan;5(1):39-44. doi: 10.1002/brb3.294. Epub 2014 Nov 13.

PMID:
25722948
[PubMed - in process]
Free PMC Article
19.

A Study Evaluating the Bidirectional Relationship Between Inflammatory Bowel Disease and Self-reported Non-celiac Gluten Sensitivity.

Aziz I, Branchi F, Pearson K, Priest J, Sanders DS.

Inflamm Bowel Dis. 2015 Feb 24. [Epub ahead of print]

PMID:
25719528
[PubMed - as supplied by publisher]
20.

DOP066. Impaired mucosal permeability underlies ongoing irritable bowel syndrome-like symptoms, in patients with inflammatory bowel disease who have achieved mucosal healing.

[No authors listed]

J Crohns Colitis. 2015 Feb;9 Suppl 1:S61-2. doi: 10.1093/ecco-jcc/jju027.094. No abstract available.

PMID:
25718280
[PubMed - in process]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk